• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
ZHANG Wenji. Postmortem distribution of carbofuran and its main metabolite benzofuranol in rats[J]. Journal of China Pharmaceutical University, 2018, 49(6): 706-710. DOI: 10.11665/j.issn.1000-5048.20180611
Citation: ZHANG Wenji. Postmortem distribution of carbofuran and its main metabolite benzofuranol in rats[J]. Journal of China Pharmaceutical University, 2018, 49(6): 706-710. DOI: 10.11665/j.issn.1000-5048.20180611

Postmortem distribution of carbofuran and its main metabolite benzofuranol in rats

More Information
  • An HPLC-MS/MS method using carbaryl as the internal standard substance was established for qualitative detection and quantitative determination of carbofuran and its main metabolite benzofuranol in bio-samples to study their postmortem distribution in rats. The rats were poisoned dead by intragastric administration of carbofuran suspension at the concentration of 1. 8 mg/mL, which was 4 times of the LD50(44 mg/kg). Then the rats were dissected at 0, 12, 24, 48, 72 and 96 hours after death to collect the their specimen(heart, liver, spleen, lung, kidney, brain, muscle, stomach, blood)and the carbofuran concentration were determined using HPLC-MS/MS method. The results showed that at 0 h after death, the carbofuran was distributed in rats was as follows: stomach> lung or liver> kidney or spleen> muscle> heart or heart blood or brain and transferred from stomach, lung and heart blood to liver, kidney and muscle over time, while the benzofuranol was distributed as follows: stomach> heart blood> liver or kidney> spleen or muscle or lung or brain > heart, and the concentration of benzofuranol in heart blood, heart, liver, spleen, and kidney had significant increase(P< 0. 05)over time. The postmortem concentration change of carbofuran and benzofuranol could be attributed to the degradation of carbofuran and the trans-tissues diffusion of carbofuran and benzofuranol. The postmortem distribution manner of carbofuran and benzofuranol and their HPLC-MS/MS analysis method could be applied to the forensic identification and help taking samples for toxicology analysis.
  • [1]
    Yun KM.Forensic Toxicokinetics(法医毒物动力学)[M].Beijing:People′s Medical Publishing House,2015:367-367.
    [2]
    Wang Y,Lu XG,Wang XH,et.al.In vivo determination of carbofuran level and its distribution in poisoned rabbits[J].Lab Med Clin(检验医学与临床),2016,3(22):3135-3137.
    [3]
    Liu L.Forensic Toxicology(法医毒理学)[M].Beijing:People′s Medical Publishing House,2010:164-164.
    [4]
    Wu MM.The forensic toxicokinetics study of carbofuran[D].Shanxi Medical University,2011.
    [5]
    Yang H,Zhou SL,Yin ML,et al.The study on photocatalytic degradation kinetics of carbofuran[J].China Environ Sci(中国环境科学),2013,33(1):82-87.
    [6]
    Shi YT,Ren F,Zhang P,et al.The determination of carbofuran in post mortem blood and viscera using LC-MS/MS[J].Chin J Forensic Med(中国法医学杂志),2015(4):426-427.
    [7]
    Han E,Kim E,Hong H,et al.Evaluation of postmortem redistribution phenomena for commonly encountered drugs[J].Forensic Sci Int,2012,219(1/2/3):265-271.
    [8]
    Fan AA,Shen YN,Zheng F,et al.The stability study of carbofuran and its metabolites in blood under different storage conditions[J].Chin J Forensic Med(中国法医学杂志),2017(6):578-582.
    [9]
    Zhao S,Zhang YF,Wang J,et al.In vivo postmortem distribution of mepiquat chloride in rats[J].J China Pharm Univ(中国药科大学学报),2013,44(2):147-150.
  • Related Articles

    [1]LU Zhipeng, XU Qinglong, CHEN Panpan, QIN Yajuan, TANG Lijun, LI Tingyou. Research progress of radioprobes targeting fibroblast activating protein[J]. Journal of China Pharmaceutical University, 2022, 53(6): 651-662. DOI: 10.11665/j.issn.1000-5048.20220603
    [2]CHEN Xin, YANG Qian, YOU Qidong, GUO Xiaoke. Advances of inhibitors targeting MLL1-WDR5 protein-protein interaction[J]. Journal of China Pharmaceutical University, 2022, 53(2): 125-136. DOI: 10.11665/j.issn.1000-5048.20220201
    [3]FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406
    [4]TANG Keqin, LIN Huaqing, LI Shuhong, DONG Lixin, LU Bohong, JIANG Hong. Advances in tumor targeted nanocrystals[J]. Journal of China Pharmaceutical University, 2020, 51(4): 418-424. DOI: 10.11665/j.issn.1000-5048.20200405
    [5]MEI Jiahao, HONG Ze, WANG Chen. Advances of drugs in targeting cGAS-STING signaling pathway[J]. Journal of China Pharmaceutical University, 2020, 51(3): 249-259. DOI: 10.11665/j.issn.1000-5048.20200301
    [6]JIANG Lu, CHEN Dandan, SUN Minjie, PING Qineng, ZHANG Can. Advances of wax matrix tablets[J]. Journal of China Pharmaceutical University, 2016, 47(4): 497-502. DOI: 10.11665/j.issn.1000-5048.20160418
    [7]YAO Guilin, WANG Haiyong, LU Tao. Advances of the uricosuric drugs[J]. Journal of China Pharmaceutical University, 2016, 47(4): 491-496. DOI: 10.11665/j.issn.1000-5048.20160417
    [8]ZHANG Fangrong, WANG Wei. Advances of synthetic lipoproteins as drug nanovectors[J]. Journal of China Pharmaceutical University, 2016, 47(2): 148-157. DOI: 10.11665/j.issn.1000-5048.20160204
    [9]LIU Fang, SUN Haopeng, YOU Qidong. Advances in small-molecule inhibitors targeting Hsp90-Cdc37 protein-protein interaction[J]. Journal of China Pharmaceutical University, 2015, 46(3): 272-278. DOI: 10.11665/j.issn.1000-5048.20150303
    [10]WANG Yazhe, ZHOU Jianping, DING Yang, WANG Wei. Advances in research of biomimetic drug delivery systems[J]. Journal of China Pharmaceutical University, 2014, 45(3): 267-273. DOI: 10.11665/j.issn.1000-5048.20140303

Catalog

    Article views PDF downloads Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return